Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

相似書籍

• Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors
  由: Wang, Wei, et al.
  出版: (2015)
• Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
  由: Chen, Z, et al.
  出版: (2016)
• Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy
  由: Gong, Zimu, et al.
  出版: (2017)
• Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia
  由: Prescott, Hillary, et al.
  出版: (2011)
• Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options
  由: Jabbour, Elias J., et al.
  出版: (2013)